Canada Life’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35K | Buy |
31,211
+18,314
| +142% | +$20.5K | ﹤0.01% | 1854 |
|
|
2025
Q1 | $19K | Sell |
12,897
-7,528
| -37% | -$11.1K | ﹤0.01% | 1942 |
|
|
2024
Q4 | $44K | Buy |
20,425
+241
| +1% | +$519 | ﹤0.01% | 1898 |
|
|
2024
Q3 | $57K | Sell |
20,184
-3,908
| -16% | -$11K | ﹤0.01% | 1938 |
|
|
2024
Q2 | $56K | Buy |
24,092
+6,342
| +36% | +$14.7K | ﹤0.01% | 1955 |
|
|
2024
Q1 | $79K | Buy |
17,750
+8,162
| +85% | +$36.3K | ﹤0.01% | 1968 |
|
|
2023
Q4 | $31K | Sell |
9,588
-2,583
| -21% | -$8.35K | ﹤0.01% | 2070 |
|
|
2023
Q3 | $39K | Hold |
12,171
| – | – | ﹤0.01% | 2073 |
|
|
2023
Q2 | $61K | Buy |
12,171
+3,344
| +38% | +$16.8K | ﹤0.01% | 1983 |
|
|
2023
Q1 | $43K | Buy |
8,827
+1,826
| +26% | +$8.9K | ﹤0.01% | 2089 |
|
|
2022
Q4 | $44K | Buy |
7,001
+777
| +12% | +$4.88K | ﹤0.01% | 2094 |
|
|
2022
Q3 | $67K | Buy |
6,224
+484
| +8% | +$5.21K | ﹤0.01% | 2055 |
|
|
2022
Q2 | $66K | Buy |
5,740
+503
| +10% | +$5.78K | ﹤0.01% | 1994 |
|
|
2022
Q1 | $50K | Buy |
5,237
+450
| +9% | +$4.3K | ﹤0.01% | 2153 |
|
|
2021
Q4 | $72K | Buy |
4,787
+439
| +10% | +$6.6K | ﹤0.01% | 2081 |
|
|
2021
Q3 | $112K | Hold |
4,348
| – | – | ﹤0.01% | 2032 |
|
|
2021
Q2 | $113K | Sell |
4,348
-201
| -4% | -$5.22K | ﹤0.01% | 2056 |
|
|
2021
Q1 | $159K | Buy |
4,549
+935
| +26% | +$32.7K | ﹤0.01% | 2002 |
|
|
2020
Q4 | $91K | Hold |
3,614
| – | – | ﹤0.01% | 2134 |
|
|
2020
Q3 | $136K | Hold |
3,614
| – | – | ﹤0.01% | 1974 |
|
|
2020
Q2 | $154K | Buy |
3,614
+1,987
| +122% | +$84.7K | ﹤0.01% | 1958 |
|
|
2020
Q1 | $32K | Hold |
1,627
| – | – | ﹤0.01% | 2254 |
|
|
2019
Q4 | $42K | Buy |
+1,627
| New | +$42K | ﹤0.01% | 2317 |
|
|
2019
Q3 | – | Sell |
-3,067
| Closed | -$82K | – | 1151 |
|
|
2019
Q2 | $82K | Buy |
+3,067
| New | +$82K | ﹤0.01% | 2284 |
|